Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 3/20 | 0.43 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.43 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.43 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.43 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | HTR2C | P28335 | 2/20 | 0.43 |
| ▸ | HTR2B | P41595 | 2/20 | 0.43 |
| ▸ | FAAH | O00519 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.43 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.43 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.43 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.43 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1470798 | 0.80 | GABRA1 (0.43) | GABRA1GABRG2GABRB3SLC6A2GABRB2 | |
| SCHEMBL29162886 | 0.77 | GABRA1 (0.50) | GABRA1GABRG2GABRB3SLC6A2GABRB2 | |
| SCHEMBL814947 | 0.76 | GABRA1 (0.38) | GABRA1GABRG2GABRB3SLC6A2GABRB2 | |
| SCHEMBL815487 | 0.76 | GABRA1 (0.38) | GABRA1GABRG2GABRB3SLC6A2GABRB2 | |
| SCHEMBL814211 | 0.76 | GABRA1 (0.38) | GABRA1GABRG2GABRB3SLC6A2GABRB2 | |
| SCHEMBL813604 | 0.76 | GABRA1 (0.38) | GABRA1GABRG2GABRB3SLC6A2GABRB2 | |
| SCHEMBL814562 | 0.76 | GABRA1 (0.38) | GABRA1GABRG2GABRB3SLC6A2GABRB2 | |
| SCHEMBL814073 | 0.76 | GABRA1 (0.35) | GABRA1GABRG2GABRB3SLC6A2GABRB2 | |
| SCHEMBL66227 | 0.73 | GABRA1 (0.57) | GABRA1GABRG2GABRB3SLC6A2GABRB2 | |
| SCHEMBL28723809 | 0.73 | CYP1A2 (0.48) | GABRA1GABRG2GABRB3SLC6A2GABRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120081790-A | Bridged double-center carbene catalyst ligand and preparation method and application thereof | 上海化工研究院有限公司 | 2025-06-03 | — | — | CN | disclosed |
| CN-115043868-A | Five-membered cyclic aminosilane external electron donor, preparation method and application thereof | 中国科学院化学研究所 | 2022-09-13 | — | — | CN | disclosed |
| EP-3083048-B1 | METAL-LIGAND COMPLEX, OLEFIN POLYMERIZATION CATALYST DERIVED THEREFROM, AND OLEFIN POLYMERIZATION METHOD UTILIZING THE CATALYST | DOW GLOBAL TECHNOLOGIES LLC (US) | 2021-04-07 | — | — | EP | disclosed |
| CN-105813742-B | Metal-ligand complex, olefin polymerization catalyst derived therefrom, and olefin polymerization method using the catalyst | 陶氏环球技术有限责任公司 | 2020-05-15 | — | — | CN | disclosed |
| US-9862734-B2 | Metal-ligand complex, olefin polymerization catalyst derived therefrom, and olefin polymerization method utilizing the catalyst | DOW GLOBAL TECHNOLOGIES LLC (US) | 2018-01-09 | — | — | US | disclosed |
| CN-104937062-B | Binder combination, binding agent, the film including it and its preparation method | 3M创新有限公司 | 2016-12-14 | — | — | CN | disclosed |
| US-20160311837-A1 | METAL-LIGAND COMPLEX, OLEFIN POLYMERIZATION CATALYST DERIVED THEREFROM, AND OLEFIN POLYMERIZATION METHOD UTILIZING THE CATALYST | DOW GLOBAL TECHNOLOGIES LLC | 2016-10-27 | — | — | US | disclosed |
| EP-3083048-A1 | METAL-LIGAND COMPLEX, OLEFIN POLYMERIZATION CATALYST DERIVED THEREFROM, AND OLEFIN POLYMERIZATION METHOD UTILIZING THE CATALYST | Dow Global Technologies LLC (US) | 2016-10-26 | — | — | EP | disclosed |
| CN-102655935-B | Metathesis catalyst and using method thereof | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2016-01-13 | — | — | CN | disclosed |
| WO-2015094513-A1 | METAL-LIGAND COMPLEX, OLEFIN POLYMERIZATION CATALYST DERIVED THEREFROM, AND OLEFIN POLYMERIZATION METHOD UTILIZING THE CATALYST | DOW GLOBAL TECHNOLOGIES LLC (US) | 2015-06-25 | — | — | WO | disclosed |
| US-9024034-B2 | Metathesis catalysts and processes for use thereof | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2015-05-05 | — | — | US | disclosed |
| EP-2498908-A2 | METATHESIS CATALYSTS AND PROCESSES FOR USE THEREOF | ExxonMobil Chemical Patents Inc. (US) | 2012-09-19 | — | — | EP | disclosed |
| WO-2011056874-A2 | METATHESIS CATALYSTS AND PROCESSES FOR USE THEREOF | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2011-05-12 | — | — | WO | disclosed |
| US-20110112302-A1 | Metathesis Catalysts and Processes for Use Thereof | EXXONMOBIL CHEMICAL PATENTS INC. | 2011-05-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110112302-A1 | Metathesis Catalysts and Processes for Use Thereof | FASN, LIPC, MGLL | GABRA1 3511/4885GABRG2 3748/4885GABRB3 3494/4885 |
| US-20160311837-A1 | METAL-LIGAND COMPLEX, OLEFIN POLYMERIZATION CATALYST DERIVED THEREFROM, AND OLEFIN POLYMERIZATION METHOD UTILIZING THE CATALYST | OPRM1, WASF2, WEE1 | GABRA1 3207/4885GABRG2 3201/4885GABRB3 3970/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.